These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 2304452

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. In vivo and in vitro binding of fatty acids to genetic variants of human serum albumin.
    Kragh-Hansen U, Nielsen H, Pedersen AO.
    Int J Clin Pharmacol Res; 1995; 15(2):33-43. PubMed ID: 8593972
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Relations between high-affinity binding sites of markers for binding regions on human serum albumin.
    Kragh-Hansen U.
    Biochem J; 1985 Feb 01; 225(3):629-38. PubMed ID: 3977850
    [Abstract] [Full Text] [Related]

  • 10. Salicylate binding by human albumin in the presence of a perfluorochemical emulsion.
    Parsons DL, Sathe RS.
    Arch Int Pharmacodyn Ther; 1991 Feb 01; 310():5-12. PubMed ID: 1772331
    [Abstract] [Full Text] [Related]

  • 11. Blood binding of selezen (imidazole salicylate) in man.
    Zini R, Morin D, Acuto GC, Bianchini C, de Santis F, Tillement JP.
    Int J Clin Pharmacol Ther Toxicol; 1991 Jun 01; 29(6):242-9. PubMed ID: 1869346
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. High-affinity binding of laurate to naturally occurring mutants of human serum albumin and proalbumin.
    Kragh-Hansen U, Pedersen AO, Galliano M, Minchiotti L, Brennan SO, Tárnoky AL, Franco MH, Salzano FM.
    Biochem J; 1996 Dec 15; 320 ( Pt 3)(Pt 3):911-6. PubMed ID: 9003380
    [Abstract] [Full Text] [Related]

  • 15. Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
    Kiriyama A, Nishiura T, Ishino M, Yamamoto Y, Ogita I, Kiso Y, Takada K.
    Biopharm Drug Dispos; 1996 Dec 15; 17(9):739-51. PubMed ID: 8968527
    [Abstract] [Full Text] [Related]

  • 16. Albumin binding of anti-inflammatory drugs. Utility of a site-oriented versus a stoichiometric analysis.
    Honoré B, Brodersen R.
    Mol Pharmacol; 1984 Jan 15; 25(1):137-50. PubMed ID: 6708930
    [Abstract] [Full Text] [Related]

  • 17. Pharmaceutical-grade albumin: impaired drug-binding capacity in vitro.
    Olsen H, Andersen A, Nordbø A, Kongsgaard UE, Børmer OP.
    BMC Clin Pharmacol; 2004 Mar 29; 4():4. PubMed ID: 15046641
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Binding of drugs to human serum albumin:XI. The specificity of three binding sites as studied with albumin immobilized in microparticles.
    Sjöholm I, Ekman B, Kober A, Ljungstedt-Påhlman I, Seiving B, Sjödin T.
    Mol Pharmacol; 1979 Nov 29; 16(3):767-77. PubMed ID: 530258
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.